Información del artículo
El Texto completo está disponible en PDF
References
[1.]
G. Francesco, A. Cristiana, L.V. Rocco, V. Marinella, E. Maurizio, R. Antonino.
Hypersensitivity to Lamotrigine and Nonaromatic Anticonvulsant Drugs: A Review.
Curr Pharm Des, 14 (2008), pp. 2874-2882
[2.]
P.D. Ghislain, A.D. Bodarwe, O. Vanderdonckt, D. Tennstedt, L. Marot, J.M. Lachapelle.
Drug-induced eosinophilia and multisystemic failure with positive patch-test reaction to spironolactone: DRESS syndrome.
Acta Derm Venereol, 84 (2004), pp. 65-68
[3.]
A. Barbaud, M. Gonc¸alo, D. Bruynzeel, A. Bircher.
Guidelines for performing skin tests with drugs in the investigation of cutaneous adverse drug reactions.
Contact Dermatitis, 45 (2001), pp. 321-328
[4.]
K. Lamminiausta, O. Kortekangas-Savolainen.
The usefulness of skin tests to prove drug hypersensitivity.
Br J Dermatol, 152 (2005), pp. 968-974
[5.]
S. Monzón, M.M. Garces, C. Reiehell, A. Lezaun, C. Colás.
Positive patch test in hypersensitivity to lamotrigine.
Contact Dermatitis, 47 (2002), pp. 361
[6.]
C.J. Hesiao, J.Y. Lee, T.W. Wong, H.M. Sheu.
Extensive fixed drug eruption due to lamotrigine.
Br J Dermatol, 144 (2001), pp. 1289-1291
[7.]
A. Barbaud.
Drug patch testing in systemic cutaneous drug allergy.
Toxicology, 209 (2005), pp. 209-216
[8.]
K. Alanko, S. Stubb, S. Reitamo.
Topical provocation of fixed drug eruption.
Br J Dermatol, 116 (1987), pp. 517-561
[9.]
K. Alanko.
Topical provocation of fixed drug eruption. A study of 30 patients.
Contact Dermatitis, 31 (1994), pp. 25-27
[10.]
L. Puig, C. Nadal, M.T. Fernández-Figueras, A. Alomar.
Carbamazepine-induced drug rashes; diagnostic value of patch test depends on clinico-pathologic presentation.
Contact Dermatitis, 34 (1996), pp. 435-437
Copyright © 2011. Academia Española de Dermatología y Venereología and Elsevier España, S.L.
